Tensions between Japan and South Korea come as the U.S. and its trading partners are embroiled in a global trade war.Technologyread more
The one-to-eight stock split would mean the current number of ordinary shares — which stands at 4 billion — will increase to 32 billion. It comes ahead of a reported Hong Kong...Asia Marketsread more
Minutes from the Reserve Bank of Australia's monetary policy meeting in July showed the central bank was ready to adjust interest rates if required.Asia Marketsread more
Current and former Tesla employees working in the company's open-air "tent" factory say they felt pressure to take shortcuts to hit aggressive Model 3 production goals,...Technologyread more
China's fiscal spending increased 10.7% in the first six months from a year earlier, the finance ministry said on Tuesday, underlining the government's bid to support the...China Economyread more
The findings by McKinsey and Company come amid a year-long tariff fight between the U.S. and China, which has spilled into areas such as technology and security.China Economyread more
Microsoft's considerable reach into the corporate world isn't something Slack CEO Stewart Butterfield is very concerned about.Technologyread more
Von der Leyen, one of the longest serving ministers in Germany, has tried to woo European lawmakers over the last two weeks.Europe Newsread more
A devastating outbreak of African swine fever that has killed millions of pigs in China is changing attitudes in a country where farm hygiene has often been seen as lax by...Livestockread more
In a closed-door meeting at a Manhattan mansion, executives outlined changes to controversial software that was implicated in two crashes.Aerospace & Defenseread more
President Donald Trump and the RNC are picking up key supporters in the business community who did not back him as a candidate in 2016.2020 Electionsread more
The plunge in Johnson & Johnson's stock price following a report suggesting the company knew about asbestos in its baby powder is overdone and "excessive," Wells Fargo told clients Friday.
Wells Fargo, which said it still believes J&J's stock will outperform despite the allegation, said the selling based purely on the outcomes of any talc litigation is likely overstated.
"Based on prior high-profile product liability cases in drug and device sectors, we believe any potential settlement should be manageable for JNJ," analyst Larry Biegelsen wrote Friday. "Even if all 11,700 talc cases settled for $280,000 per case (the highest per case settlement amount among the cases we've tracked), the total liability to JNJ would be $3.3 billion. With over $19 billion of cash and marketable securities at the end of the third quarter, we continue to see the talc litigation as manageable for the company."
J&J shares sank as much as 11.9 percent on Friday after Reuters reported that the company knew for decades that its iconic talcum power contained asbestos. Reuters said its review showed that from 1971 to the early 2000s, J&J executives, mine managers, doctors and lawyers were aware the company's raw talc and finished powders sometimes tested positive for small amounts of asbestos. Though the problem was discussed, it was never disclosed to regulators or the public, Reuters reported.
Johnson & Johnson offered the following statement in response to the Reuters report:
"The Reuters article is one-sided, false and inflammatory. Simply put, the Reuters story is an absurd conspiracy theory, in that it apparently has spanned over 40 years, orchestrated among generations of global regulators, the world's foremost scientists and universities, leading independent labs, and J&J employees themselves," the company said in a statement. "Johnson & Johnson's baby powder is safe and asbestos-free."
The Reuters report represents the latest in a string of talc-related headaches for the company, which prides itself on the safety and family-friendly reputation of its products.
A jury in St. Louis concluded in July that the consumer drugmaker should pay $4.69 billion in damages to 22 women and their families who brought a tort suit. Johnson & Johnson said it was "deeply disappointed" with the jury's decision.
Citigroup analyst Amit Hazah noted that every court case decision that has been appealed has been overturned in Johnson & Johnson's favor.
"While we want to steer clear of giving a strong prediction on the outcome of the ongoing talc litigation given its breadth and complexity, we do want to note that response from management," Hazah wrote. We'd "highlight the robust cash generation capabilities of the company ... the product category itself" makes up less than 0.02 percent of total J&J sales.